Morgan Stanley Downgrades Exelon to Equal-Weight, Lowers Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst David Arcaro has downgraded Exelon (NASDAQ:EXC) from Overweight to Equal-Weight and reduced the price target from $45 to $38.

December 18, 2023 | 11:04 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Exelon Corporation's stock rating was downgraded by Morgan Stanley from Overweight to Equal-Weight, and the price target was lowered from $45 to $38.
Analyst downgrades typically lead to a negative short-term reaction in the stock market as they suggest a less optimistic outlook on the company's future performance. The reduction in the price target further implies that the analyst sees less upside potential in the stock, which could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100